Certara Investor Relations Material
Latest events
Q2 2024
Certara
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Certara Inc
Access all reports
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. Established in 1997, Certara empowers customers to make better decisions with science-driven guidance across a breadth of therapeutic areas including cardiovascular, oncology, central nervous system disorders and rare diseases. Certara's solutions are used by top pharmaceutical companies around the world including Merck & Co., Inc., Pfizer Inc., Novartis AG and Johnson & Johnson Services Inc. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.
Key slides for Certara Inc
Investor Presentation
Certara Inc
Q2 2024
Certara Inc
Latest articles
Cristiano Amon: Qualcomm's 5G Specialist CEO
Cristiano Amon, Qualcomm CEO, has spent two decades at the company while taking on several roles, developing both technical and business expertise.
16 Sep 2024
Qualcomm: Quality Communication and Semiconductor Innovation
Founded in 1985, Qualcomm has transformed the digital communication industry with CDMA technology and its advanced semiconductor business.
13 Sep 2024
Strong Opinions, Loosely Held: Pontus Dackmo on Flexibility and Market Psychology
After a two-decade career in finance, Pontus Dackmo co-founded Protean Funds Scandinavia in 2022, where he now serves as CEO and Investment Manager.
4 Sep 2024
Ticker symbol
CERT
Country
🇺🇸 United States